Creador, a private equity firm, and InvAscent, an Indian Life Sciences Fund, agreed to invest $68m in Accumax, a maker of laboratory consumables and benchtop equipment. "Accumax is poised to benefit from the increased global focus and investments in vaccines, bioharma and pharma research activities post the COVID-19 pandemic," Sumit Gupta, InvAscent Managing Director.